| Patient | John F. Kennedy |
|---|---|
| Date of birth | 1995-05-29 |
| Identifiers | MRN HR-ML023-SYN; SSN (made up) 000-23-5408 |
| Document date | 2026-01-26 |
| Author | Harlan Prescott, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Two-week review, seen the same day by endocrinology, with a bone density scan this morning. [S]
Mr. Kennedy returns two weeks after his first visit and is seen by Dr. Desai of endocrinology on the same day. He takes hydrocortisone 20 mg on waking and 10 mg at 2 pm and fludrocortisone half a tablet each morning, as the hospital prescribed, and has missed no doses. His energy is better than at discharge but fades by late afternoon. He craves salty food and feels lightheaded for a few seconds when he stands up quickly; he has not fainted. His appetite is good and he has gained a little weight. He has no nausea or abdominal pain. He started physical therapy last week and has done his exercises daily; his back still aches after long sitting and he wears the brace for the drive to work. He uses acetaminophen once or twice a day. He has practised with the trainer injection kit. He had his bone density scan this morning. [S]
| Element | Detail |
|---|---|
| Replacement | Hydrocortisone 30 mg a day and fludrocortisone 0.05 mg a day since the hospital; no missed doses |
| Symptoms | Salt craving; brief lightheadedness on standing; afternoon tiredness |
| Weight | 66.8 kg, up from 66.0 |
| Back | Aches after sitting; first physical therapy session last week; acetaminophen once or twice a day |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Tired by late afternoon; weight up 0.8 kg |
| Cardiovascular | Positive | Brief lightheadedness on standing quickly; no fainting or palpitations |
| Gastrointestinal | Positive | Salt craving; no nausea, vomiting, or abdominal pain |
| Musculoskeletal | Positive | Low back ache after long sitting; no leg pain |
| Endocrine | Negative | No cold intolerance, constipation, or dry skin |
5 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Hydrocortisone 10 mg oral tablet, two tablets (20 mg) on waking and one tablet (10 mg) at 2 pm, 30 mg a day (started in hospital) | Two tablets on waking and one tablet at 2 pm | Oral route | 2025-10-06 to 2026-01-26 | completed | S |
| Fludrocortisone 0.1 mg oral tablet, half a tablet (0.05 mg) by mouth once daily (started in hospital) | Half a tablet by mouth once daily | Oral route | 2025-10-06 to 2026-01-26 | completed | S |
| Hydrocortisone 10 mg oral tablet, one tablet by mouth on waking | One tablet by mouth on waking | Oral route | 2026-01-26 | active | S |
| Hydrocortisone 5 mg oral tablet, one tablet by mouth at noon and one at 4 pm | One tablet at noon and one tablet at 4 pm (two doses a day) | Oral route | 2026-01-26 | active | S |
| Fludrocortisone 0.1 mg oral tablet, one tablet by mouth once daily | One tablet by mouth once daily | Oral route | 2026-01-26 | active | S |
| Hydrocortisone 100 mg injection kit (with diluent), 100 mg into the thigh muscle once for vomiting, collapse or signs of adrenal crisis, then call 911 | Once, as needed for adrenal crisis; carry at all times | Intramuscular route | 2026-01-12 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets by mouth up to three times a day as needed for back pain | Two tablets up to three times a day as needed | Oral route | 2026-01-12 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-01-26 | Body height | 183 | cm | S |
| 2026-01-26 | Body weight | 66.8 | kg | S |
| 2026-01-26 | Body mass index (BMI) [Ratio] | 19.9 | kg/m2 | S |
| 2026-01-26 | Systolic blood pressure | 108 | mm[Hg] | S |
| 2026-01-26 | Diastolic blood pressure | 68 | mm[Hg] | S |
| 2026-01-26 | Heart rate | 84 | /min | S |
| 2026-01-26 | Respiratory rate | 14 | /min | S |
| 2026-01-26 | Body temperature | 36.7 | Cel | S |
| 2026-01-26 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-01-26 | DXA Lumbar spine [Z-score] Bone density | -1.3 | {Z-score} | Above -2.0 is within the expected range for age | Normal | S |
| 2026-01-26 | DXA Femur [Z-score] Bone density | -0.6 | {Z-score} | Above -2.0 is within the expected range for age | Normal | S |
Vital signs recorded on 2026-01-26; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Thin, alert; weight 66.8 kg |
| Blood pressure lying and standing | 110/70 lying, pulse 84; 96/62 after three minutes standing, pulse 100: a postural drop of 14 mmHg systolic |
| Skin and mouth | Tan-brown pigmentation of the palmar creases, knuckles and gums; no thin skin, striae, or bruising |
| Neck | Thyroid slightly firm, not enlarged |
| Extremities | No ankle edema |
| Back | Healed midline lumbar scar; paraspinal muscles tender; forward flexion to mid-thigh; straight-leg raising negative; strength, reflexes and sensation in the legs normal |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Primary adrenal insufficiency (Addison's disease), diagnosed about three months ago during an adrenal crisis while traveling abroad, on hydrocortisone and fludrocortisone; synthetic modern episode linked to his documented 1947 diagnosis | active | confirmed | E27.1 | S — Synthetic modern coding of the documented diagnosis. |
| Chronic low back pain persisting after lumbar disc surgery; began after a football injury in college and worsened during wartime naval service; uses a corset brace; synthetic modern episode linked to his documented back history | active | confirmed | M96.1 | S — Synthetic modern coding of the documented back pain and operation. |
| Raised TSH with positive thyroid peroxidase antibodies and normal free T4 on screening for associated autoimmune disease; to be repeated before any treatment | active | confirmed | R94.6 | S — Synthetic screening finding. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Glucocorticoid dose: weight, energy, and signs of under- or over-replacement | Every visit | Completed today | Afternoon tiredness on 30 mg a day, weight 66.8 kg, no signs of excess; reduced to 20 mg a day in three doses on the consultant's advice |
| Examination | Blood pressure lying and standing | Every visit | Completed today | 110/70 lying, 96/62 standing: postural drop of 14 mmHg |
| Laboratory | Mineralocorticoid: salt craving, edema, sodium and potassium | After any fludrocortisone change, then at least yearly | Up to date | Sodium 134 and potassium 5.2 mmol/L at intake, with salt craving; fludrocortisone raised to 0.1 mg today; recheck in six weeks |
| Laboratory | Plasma renin activity | After any fludrocortisone change, then at least yearly; aim for the upper normal range | Up to date | 9.6 ng/mL/h at intake, raised; recheck in six weeks |
| Self-management | Sick-day rules, emergency injection kit, steroid card, and medical ID | Every visit | Completed today | Rules stated back; practice injection on the trainer; kit, card and medical ID with him |
| Laboratory | Cause: 21-hydroxylase antibodies | Once, at diagnosis | Up to date | Positive at intake (18 U/mL): autoimmune adrenalitis; no adrenal imaging needed |
| Laboratory | TSH and free T4 | Confirmatory repeat 2 to 3 months after a newly abnormal TSH, before treatment (CMID); TSH at least yearly in adrenal insufficiency | Due | TSH 7.4 mIU/L with normal free T4 and positive antibodies at intake; repeat at the six-week visit |
| Laboratory | Other associated autoimmune disease: vitamin B12, A1c, and celiac serology | At diagnosis, then yearly or with symptoms | Up to date | Vitamin B12 455 pg/mL, A1c 5.1%, tissue transglutaminase IgA 1.1 U/mL with total IgA 214 mg/dL at intake: no other associated disease found |
| Imaging | Bone density (DXA) | Once now because of earlier corticosteroid exposure; repeat only if risk rises | Completed today | Lumbar spine Z-score -1.3, total hip Z-score -0.6: within the expected range for age |
| Survey | Oswestry Disability Index | Each back pain review | Up to date | 32% at intake; next at the six-week visit |
| Self-management | Exercise therapy, physical therapy, and brace use | Weekly to twice weekly physical therapy, daily home program | Completed today | First session done; home exercises daily; brace for driving only |
| Medication safety | Analgesic use | Every visit | Completed today | Acetaminophen 1 g once or twice a day; no NSAID or opioid |
| Referral | Endocrinology review | At diagnosis, then at least yearly | Completed today | Seen by Dr. Desai today |
Goal progress:
Guideline basis: Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016); Guidelines for the treatment of hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014); Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians (2017); 2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis (2022); Osteoporosis in men: an Endocrine Society clinical practice guideline (2012); American College of Gastroenterology Guidelines Update: Diagnosis and Management of Celiac Disease (2023); CMID: Clinical Monitoring Intelligence Database, hypothyroidism monograph (2026)
Follow-up: Six-week visit with sodium, potassium, creatinine, renin, TSH, free T4 and the Oswestry score. Call the clinic for fever, vomiting or feeling faint, and follow the sick-day rules. Next scheduled visit 2026-03-09: six-week review after the dose changes: electrolytes, renin, repeat thyroid tests, and back pain. [S]